nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aiello S, Gastoldi S, Galbusera M, et al. C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19. Blood Adv. 2022;6(3):866-881.
|
|
|
|
6 |
9 |
p. 2812 |
artikel |
2 |
A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapy
|
Gouni, Sushanth |
|
|
6 |
9 |
p. 2757-2762 |
artikel |
3 |
Analysis of preplatelets and their barbell platelet derivatives by imaging flow cytometry
|
Kemble, Samuel |
|
|
6 |
9 |
p. 2932-2946 |
artikel |
4 |
A novel mouse model of type 2N VWD was developed by CRISPR/Cas9 gene editing and recapitulates human type 2N VWD
|
Shi, Qizhen |
|
|
6 |
9 |
p. 2778-2790 |
artikel |
5 |
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera
|
Guglielmelli, Paola |
|
|
6 |
9 |
p. 2927-2931 |
artikel |
6 |
Benefits of newborn screening and hematopoietic cell transplant in infantile Krabbe disease
|
Page, Kristin M. |
|
|
6 |
9 |
p. 2947-2956 |
artikel |
7 |
Changes in body mass index, weight, and height in children with acute myeloid leukemia and the associations with outcome
|
Iijima, Mayuko |
|
|
6 |
9 |
p. 2824-2834 |
artikel |
8 |
Day 30 SUVmax predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy
|
Al Zaki, Ajlan |
|
|
6 |
9 |
p. 2867-2871 |
artikel |
9 |
Deficiency of SARS-CoV-2 T-cell responses after vaccination in long-term allo-HSCT survivors translates into abated humoral immunity
|
Einarsdottir, Sigrun |
|
|
6 |
9 |
p. 2723-2730 |
artikel |
10 |
Differential impact of tamoxifen and aromatase inhibitors on thrombin generation: the prospective HEMOBREAST cohort
|
Blondon, Marc |
|
|
6 |
9 |
p. 2884-2892 |
artikel |
11 |
Distinct clinical and genetic features of hepatitis B virus–associated follicular lymphoma in Chinese patients
|
Ren, Weicheng |
|
|
6 |
9 |
p. 2731-2744 |
artikel |
12 |
Editorial Board
|
|
|
|
6 |
9 |
p. i |
artikel |
13 |
Historical expectations with DNA methyltransferase inhibitor monotherapy in MDS: when is combination therapy truly “promising”?
|
Brunner, Andrew M. |
|
|
6 |
9 |
p. 2854-2866 |
artikel |
14 |
Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey
|
Harkins, R. Andrew |
|
|
6 |
9 |
p. 2745-2756 |
artikel |
15 |
Novel cysteine substitution p.(Cys1084Tyr) causes variable expressivity of qualitative and quantitative VWF defects
|
Rawley, Orla |
|
|
6 |
9 |
p. 2908-2919 |
artikel |
16 |
Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy
|
Versluis, Jurjen |
|
|
6 |
9 |
p. 2835-2846 |
artikel |
17 |
Prognostic impact of ABCA3 expression in adult and pediatric acute myeloid leukemia: an ALFA-ELAM02 joint study
|
Ceraulo, Antony |
|
|
6 |
9 |
p. 2773-2777 |
artikel |
18 |
Rapid next-generation sequencing aids in diagnosis of transient abnormal myelopoiesis in a phenotypically normal newborn
|
Aziz-Bose, Rahela |
|
|
6 |
9 |
p. 2893-2896 |
artikel |
19 |
Results of a United Kingdom real-world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory DLBCL
|
Northend, Michael |
|
|
6 |
9 |
p. 2920-2926 |
artikel |
20 |
RNA sequencing of chronic GVHD skin lesions defines shared and unique inflammatory pathways characterizing lichen planus and morphea
|
Zouali, Habib |
|
|
6 |
9 |
p. 2805-2811 |
artikel |
21 |
Scheduled administration of virus-specific T cells for viral prophylaxis after pediatric allogeneic stem cell transplant
|
Rubinstein, Jeremy D. |
|
|
6 |
9 |
p. 2897-2907 |
artikel |
22 |
Single-cell analysis reveals selection of TP53-mutated clones after MDM2 inhibition
|
Maslah, Nabih |
|
|
6 |
9 |
p. 2813-2823 |
artikel |
23 |
Single-cell immune profiling reveals a developmentally distinct CD4+ GM-CSF+ T-cell lineage that induces GI tract GVHD
|
Piper, Clint |
|
|
6 |
9 |
p. 2791-2804 |
artikel |
24 |
Structure of shear-induced platelet aggregated clot formed in an in vitro arterial thrombosis model
|
Kim, Dongjune A. |
|
|
6 |
9 |
p. 2872-2883 |
artikel |
25 |
TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML
|
Weinberg, Olga K. |
|
|
6 |
9 |
p. 2847-2853 |
artikel |
26 |
Utility of PET/CT in assessing early treatment response in patients with newly diagnosed multiple myeloma
|
Charalampous, Charalampos |
|
|
6 |
9 |
p. 2763-2772 |
artikel |